Ramucirumab: A New Therapy for Advanced Gastric Cancer

J Adv Pract Oncol. 2015 Jan-Feb;6(1):71-5. doi: 10.6004/jadpro.2015.6.1.8.

Andrea Landgraf Oholendt ¹, Jennifer L Zadlo ¹

Affiliations

Affiliation

1 The University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 26413377 DOI: 10.6004/jadpro.2015.6.1.8

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-P9920

Ramucirumab

99.40%, VEGFR-2 Antagonist

VEGFR

Cancer
HY-P9920A

Ramucirumab (anti-VEGFR)

99.36%, VEGFR-2 Antagonist

VEGFR

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us